Today: 21 July 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation. Follow Marcin Frąckiewicz on Google News, Facebook. or Linkedin.

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 30.06.2026

LIVEMarkets rolling coverageStarted: June 30, 2026, 4:00 AM EDTUpdated: July 1, 2026, 3:59 AM EDT ASX 200 Drops 0.6% to Start New Fiscal Year as Global Jitters Weigh July 1, 2026, 3:54 AM EDT. The ASX 200 slid 0.6% to 8,723 at Wednesday’s open for the new financial year. Traders pointed to weak risk appetite after U.S. futures slipped, following strong H1 2026 gains and as the market braced for May trade numbers. Selling hit commercial services, financials, logistics and consumer names. Australia’s big four banks lost around 1.5%-2.5%. Building permits extended their fall for a third straight month. Minutes
30 June 2026
··
Abivax (NASDAQ:ABVX) ADS gain $2.3B after obefazimod safety news; Paris session yet to start

Abivax (NASDAQ:ABVX) ADS gain $2.3B after obefazimod safety news; Paris session yet to start

Abivax S.A. is set for a lagged Paris opening after its U.S. ADS jumped in after-hours trading. Investors reacted to new clinical data on obefazimod, Abivax’s ulcerative colitis drug. The latest news hits late, but the drop earlier this month wasn’t about whether the drug works. It was about the potential cancer risk and what that could mean for the drug’s label.
30 June 2026
···
Concentrix (NASDAQ:CNXC) stock sinks on Q2 guidance cut as cash flow rises

Concentrix (NASDAQ:CNXC) stock sinks on Q2 guidance cut as cash flow rises

Concentrix Corporation lost more than a fifth of its market value in after-hours trading on Monday after the customer-experience services company gave a soft outlook, even as its second-quarter cash flow improved. The stock last traded at $19.55, down 22.5%, after closing up 0.9% at $25.23; after-hours volume was 1.07 million shares, MarketWatch data showed.
30 June 2026
···
Nasdaq bounce hides thin megacap recovery as US stocks end

Nasdaq bounce hides thin megacap recovery as US stocks end

U.S. stocks climbed Monday, but the close didn’t fully back up the day’s upbeat numbers. The Nasdaq led gains, S&P 500 rose over 1%, and the Dow crossed 52,000. Even so, there weren’t many fresh highs and breadth stayed moderate. The move seemed more about big-cap names bouncing than a real broad rally heading into the end of the quarter.
29 June 2026
········
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.06.2026

LIVEMarkets rolling coverageStarted: June 29, 2026, 4:00 AM EDTUpdated: June 30, 2026, 3:59 AM EDT Harvest Minerals (AIM: HMI) posts 2025 results, flags Brazil project hurdles June 30, 2026, 3:59 AM EDT. Harvest Minerals Limited said in its 2025 audited results that the Arapua Fertiliser Project in Brazil faced operational challenges. The AIM-listed fertiliser group sold 25,983 tonnes and is focused on keeping Arapua running and working out new debt terms as it faces global headwinds. Early-stage rare earth element (REE) exploration at Arapua looks promising, the company said. Harvest raised £300,000 from a placing and warrants, and director fees
29 June 2026
·
1 … 9 10 11 12 13 … 407

Stock Market Today

  • Lithium Americas (TSX:LAC) Shares Appear Undervalued on Book Value, But Broader Outlook Remains Unclear
    July 21, 2026, 4:39 PM EDT. Lithium Americas (TSX:LAC) shares have dropped 37.4% this year, highlighting uncertain investor sentiment. The stock is valued at a price-to-book ratio of 0.8x, lower than the industry average of 2.5x, suggesting potential undervaluation based on book value. Yet, lengthy development timelines and operational risks at the Thacker Pass project weigh on broader assessments, resulting in a neutral valuation picture with no decisive signal for investors.
Go toTop